Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-17T17:42:57.411Z Has data issue: false hasContentIssue false

Invisible Effects of Chemotherapy

Published online by Cambridge University Press:  23 March 2020

D. Brandão
Affiliation:
Interna Psiquiatria ULSAM, Departamento de Psiquiatria e Saúde Mental da ULSAM, Braga, Portugal University of Porto, Department of Clinical Neurosciences and Mental Health Faculty of Medicine, Porto, Portugal
T. Assunção
Affiliation:
IPO-Porto, Porto, Portugal University of Porto, Department of Clinical Neurosciences and Mental Health Faculty of Medicine, Porto, Portugal
H. Almeida
Affiliation:
Hospital Magalhães Lemos, B, Porto, Portugal University of Porto, Department of Clinical Neurosciences and Mental Health Faculty of Medicine, Porto, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Chemotherapy is an essential component in the treatment and alleviation of oncological diseases. To your application are associated, as well as systemic effects, cognitive impairment in patients. These changes have received increasing attention due to the impact on quality of life of cancer survivors.

Objectives

This study aims to evaluate the current evidence on the association between chemotherapy and cognitive impairment in cancer patients, especially in the areas affected cognitive function, possible mechanisms of action and consequences on the quality of life of these patients and the importance of identifying strategies intervention in order to minimize these effects.

Methods

We conducted a literature review from literature articles addressing this topic with use of databases: Medline and Pubmed. The following keywords were used: “chemobrain”, “cognitive dysfunction”, “chemotherapy”.

Results

Although some states have not found differences, several studies have shown that chemotherapy has implications cognitively. Underlying etiology remains unknown, and proposed several mechanisms to explain these changes: neurotoxicity, microvascular damage and inflamamatory response. Cognitive impairment has significant implications in the daily life of patients both personally, socially and labour. The therapeutic approach focuses on the patient and family education, coping strategies, cognitive rehabilitation and cognitive behavioural therapy.

Conclusions

It is vital to educate patients about the possibility of cognitive change as effect of chemotherapy as well as health professionals in the early identification of these changes. It is essential developing specific intervention strategies to improve the quality of life of the oncologic patient during and after treatment.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster Viewing: Oncology and psychiatry
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.